Prognostic significance of nuclear hepatoma-derived growth factor expression in gallbladder cancer

doi:10.3748/wjg.v20.i28.9564

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 28

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5387)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-5) series.

Item

Count

PDF

319

WORD

277

HTML

2799

Figures (1-1)

240

Tables (1-5)

205

Sum=3840

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

764

Download

783

Sum=1547

Jul 28, 2014 (publication date) through Jan 20, 2025

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Jul 28, 2014; 20(28): 9564-9569
Published online Jul 28, 2014. doi: 10.3748/wjg.v20.i28.9564

Table 3 Correlation between patient survival time and hepatoma-derived growth factor expression

Survival time	Cases (n)	HDGF
Survival time	Cases (n)	Positive cases	χ²	P value
< 1 yr	28	25 (89.3)	5.352	0.021
≥ 1 yr	12	6 (50.0)	5.352	0.021

HDGF: Hepatoma-derived growth factor.

Citation: Tao F, Ye MF, Sun AJ, Lv JQ, Xu GG, Jing YM, Wang W. Prognostic significance of nuclear hepatoma-derived growth factor expression in gallbladder cancer. World J Gastroenterol 2014; 20(28): 9564-9569
URL: https://www.wjgnet.com/1007-9327/full/v20/i28/9564.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i28.9564